肺癌系统淋巴结清扫
- 格式:ppt
- 大小:13.31 MB
- 文档页数:32
系统性淋巴结清扫和取样治疗早期肺癌的效果及安全性作者:秦大磊陈亮耿玉六来源:《中国医药导报》2020年第23期[摘要] 目的分析早期肺癌系统性淋巴结清扫术的疗效以及并发症。
方法选取2016年8月—2019年10月在皖北煤电集团总医院心胸外科就诊并进行手术治疗的早期非小细胞肺癌患者资料80例,根据是否进行系统性淋巴结清扫和取样分为研究组(系统性淋巴结清扫和取样)和对照组(常规手术),每组各40例。
对患者的临床病历资料进行回顾性分析,比较两组围术期指标、安全性指标。
结果研究组手术时间、住院时间长于对照组,差异有统计学意义(P < 0.05);两组切口长度、术中出血、引流管拔除时间比较,差异无统计学意义(P > 0.05);两组术后并发症发生率比较,差异无统计学意义(P > 0.05)。
结论系统性淋巴结清扫和取样并不会增加患者术后并发症的发生率,且有益于改善患者预后情况,值得临床运用推广。
[关键词] 早期;肺癌;系统性;淋巴结清扫术;取样;并发症[中图分类号] R734.205 ; ; ; ; ;[文献标识码] A ; ; ; ; ;[文章编号] 1673-7210(2020)08(b)-0099-04[Objective] To analyze the effect and complications of systemic lymphadenectomy for early lung cancer. Methods The data of 80 patients with early stage non-small cell lung cancer who were treated in the Department of Cardiothoracic Surgery, General Hospital of Wanbei Coal and Power Group from August 2016 to October 2019 were selected, they were divided into research group (systemic lymph node cleaning and sampling) and control group (normal operation) according to whether the systematic lymph node cleaning and sampling was, with 40 cases in each group. The clinical data of the patients were analyzed retrospectively, and the perioperative indexes and safety indexes of the two groups were compared. Results The operation time and hospitalization time of the research group were longer than those of the control group, and the differences were statistically significant (P < 0.05). There was no significant differences in incision length, intraoperative bleeding and drainage tube removal time between the two groups (P > 0.05). There was no statistically significant difference in the incidence of postoperative complications between the two groups (P > 0.05). Conclusion Systematic lymph node dissection and sampling will not increase the incidence of postoperative complications, and it is beneficial to improve the prognosis of patients, which is worthy of clinical application and promotion.[Key words] Early stage; Lung cancer; Systemic; Lymphadenectomy; Sampling; Complications肺癌是發病率和死亡率均很高的恶性肿瘤之一,晚期肺癌容易发生远处转移,而其途径多见于淋巴结转移[1]。